People · Operator

David K. Bonita, M.D.

Named in public records as an officer, director or promoter · active 2023–2024 · Pharma

1
Companies
2
Filings
$413.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Mirador Therapeutics, Inc.—PharmaSeries D+$413.0M$4.0B2023
Operator network

David K. Bonita, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Kristina K. Burow · 2 companies · 1 sharedKristina K. BurowMark C. McKenna · 2 companies · 1 sharedMark C. McKennaPaul K. Berns · 2 companies · 1 sharedPaul K. BernsTimothy K. Andrews · 2 companies · 1 sharedTimothy K. AndrewsJoseph K. Papa · 1 companies · 1 sharedJoseph K. PapaScott K. Glenn · 1 companies · 1 sharedScott K. GlennVika K. Brough · 1 companies · 1 sharedVika K. BroughMirador Therapeutics, Inc. · $413.0M raisedMirador Therapeutics,…David K. Bonita, M.D.DM
David K. Bonita, M.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David K. Bonita, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Kristina K. Burow12
Timothy K. Andrews12
Mark C. McKenna12
Paul K. Berns12
Scott K. Glenn11
Vika K. Brough11
Joseph K. Papa11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.